top of page

Soleus Capital Initiates Discussions with Board and Management of Theratechnologies (THTX) on Value Enhancement Strategies

Key Summary: On November 28, 2023, Soleus Capital (10.5%) communicated with the Board and management about enhancing stockholder value, including the potential appointment of a designated candidate to the Board and engaging an investment bank for strategic transactions.

Market Cap: $104 million | Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. 


On November 28, 2023, Soleus Capital (10.5%) communicated with the Board and management about enhancing stockholder value, including the potential appointment of a designated candidate to the Board and engaging an investment bank for strategic transactions. Source

Share


1 view0 comments

Recent Posts

See All

Comments


bottom of page